The big picture
One pathway is covered by insurance. The rest aren't — yet.
The honest summary: ketamine (as Spravato) is the only psychedelic-adjacent therapy currently covered by most insurance plans. Everything else — retreats, off-label IV ketamine, MDMA therapy, psilocybin sessions — is out-of-pocket. Clinical trials are the main path to free access for everything else.
| Medicine / pathway |
Insurance covered? |
Typical out-of-pocket range |
Access |
| 💉 Spravato (esketamine) |
✓ Yes — most major plans |
$10–$50/session with insurance |
All 50 states, certified clinics |
| 💉 Ketamine IV (off-label) |
✗ Generally not covered |
$400–$800/infusion · $2,400–$5,000/course |
All 50 states, ketamine clinics |
| 💉 KAP (Ketamine-Assisted Psychotherapy) |
◑ Therapy billed separately |
$500–$1,500/session · $5,000–$12,000/course |
All 50 states, select clinics |
| 🍄 Oregon/Colorado psilocybin session |
✗ Not covered |
$1,500–$3,500/session (all-in) |
Oregon & Colorado licensed centers |
| 🌿 Psilocybin retreat (international) |
✗ Not covered |
$2,000–$14,000/retreat (all-inclusive) |
Jamaica, Netherlands, Mexico, Peru + more |
| 🔬 MDMA-assisted therapy |
✗ Not FDA approved (2024) |
$3,000–$8,000/full course |
Clinical trials or underground/international |
| 🌱 Ibogaine treatment |
✗ Not covered |
$5,000–$18,000/treatment |
Mexico, Portugal, and other international |
| 🔭 Microdosing |
✗ Not covered (illegal) |
Variable — no formal cost structure |
Unregulated — see legal map |
| 🧪 Clinical trial (any medicine) |
✓ Sponsored — free to participant |
Free · some pay stipends of $50–$300/visit |
ClinicalTrials.gov · major research centers |
The insurance landscape is changing — slowly. Psilocybin's FDA review is anticipated in 2026; if approved, insurance coverage would follow, though likely only for approved indications and with prior authorization requirements similar to Spravato. MDMA therapy requires an additional Phase 3 trial after the FDA's 2024 rejection of Lykos's application. Until approval happens, out-of-pocket remains the norm for everything except Spravato.
Most accessible legally
Ketamine — three formats, three price points
Ketamine is available in the US through three distinct formats that differ significantly in cost, insurance coverage, and therapeutic depth. Understanding the difference matters before you call a clinic.
💊
Spravato (esketamine nasal spray)
FDA-approved · Administered in certified clinic · Insurance covered
✓ Insurance covered
| Phase | Frequency | Cost without insurance | Cost with insurance |
|---|
| Induction (month 1) | Twice weekly | $4,700–$7,000 | $20–$200 total (most plans) |
| Induction (month 2) | Once weekly | $2,400–$3,500/mo | $10–$100/mo |
| Maintenance | Every 1–2 weeks | $590–$885/session | $10–$50/session |
💡
Janssen's SpravatoWithMe program caps your copay at $10/session (up to $8,150 annual benefit) if you have qualifying commercial insurance. Most major insurers — Medicare Part B, Medicaid, Blue Cross, Aetna, Cigna, UnitedHealthcare, Tricare — cover Spravato with prior authorization. Medicare pays 80% after deductible.
See the full insurance walkthrough →
💉
IV Ketamine infusions (off-label)
Legal · Off-label use · Generally not covered by insurance
✗ Not typically covered
| Format | Per session | Standard course | Maintenance |
|---|
| IV infusion | $400–$800 | 6 infusions = $2,400–$5,000 | $400–$800/month |
| IM injection | $300–$600 | 6 sessions = $1,800–$3,600 | $300–$600/month |
| At-home oral/sublingual | $150–$300/mo | Ongoing | Same |
💡 Some clinics offer payment plans or sliding scale fees. HSA and FSA accounts can typically be used for IV ketamine — worth checking with your plan. Some patients successfully use out-of-network benefits (usually 50–70% reimbursement) if their plan has them. The therapy component of a visit may be billable to insurance separately even when the drug isn't.
🧠
KAP — Ketamine-Assisted Psychotherapy
Combines drug session with active therapy · Higher cost, better outcomes
◑ Therapy sometimes covered
| Component | Cost range | Insurance? |
|---|
| Preparation sessions (2–3) | $150–$350/session | Often covered as psychotherapy |
| KAP session (drug + therapy) | $500–$1,500 | Drug rarely; therapy sometimes |
| Integration sessions (3–6) | $150–$350/session | Often covered as psychotherapy |
| Full KAP course | $5,000–$12,000 | Partial — therapy only |
💡 The psychotherapy component of KAP (preparation and integration sessions) is often billable to insurance as standard psychotherapy. Only the drug administration itself is typically out-of-pocket. Ask clinics to break out billing accordingly — some have in-house insurance coordinators who handle this.
🏥
Telehealth ketamine has lowered the cost floor significantly. Companies like Mindbloom offer at-home oral ketamine programs starting around $150–$250/month with a subscription model. The therapeutic depth is lower than IV/IM, but for people primarily seeking antidepressant maintenance rather than deep psychological work, it's a meaningful cost reduction. Not appropriate for everyone — see the
ketamine centers guide for format comparison.
How insurance actually works
Getting Spravato covered — step by step
Spravato has the most mature insurance infrastructure of any psychedelic-adjacent treatment. Most denials come from incomplete documentation, not ineligibility — understanding the process significantly improves approval odds.
1
Confirm eligibility criteria
Most insurers require documentation of: (1) diagnosis of treatment-resistant depression or MDD with suicidal ideation, (2) failure of at least two adequate antidepressant trials at therapeutic doses. Your prescriber needs to document this clearly.
2
Choose a REMS-certified center
Spravato must be administered at a certified Spravato treatment center — you can't take it home. Use the Spravato treatment locator at spravato.com to find in-network certified locations near you.
3
Submit prior authorization
Your provider submits a prior authorization request with your treatment history, failed medications, and clinical justification. Most certified centers have dedicated insurance coordinators who handle this. Budget 1–4 weeks for approval.
4
If denied — appeal
30% of initial Spravato denials are overturned on appeal with proper documentation. Request a peer-to-peer review (your doctor speaks directly with the insurance medical director). Have your psychiatrist document why alternatives failed.
5
Apply to SpravatoWithMe
Janssen's patient assistance program caps your copay at $10/session (max $8,150 annual benefit) for commercially insured patients. Even with good coverage, this eliminates most out-of-pocket. Apply through your treatment center.
Which insurers cover Spravato
Medicare Part B
✓ Covers 80% after deductible
Must be administered in REMS-certified facility. Medigap covers the remaining 20%.
Medicaid
◑ Varies by state
Most states cover; some require prior auth or have copays. Check your state's formulary.
Blue Cross Blue Shield
✓ Covered
Prior authorization required. Criteria: TRD + 2 failed antidepressants.
Aetna
✓ Covered
Prior authorization required. Criteria align with FDA approval.
Cigna
✓ Covered
Prior authorization required. Documentation of treatment history essential.
UnitedHealthcare
✓ Covered
Prior authorization required. One of the largest networks of certified sites.
Tricare
✓ Covered
Relevant for veterans and military. Growing psychedelic therapy coverage being explored by VA.
Enthea
◑ Ancillary benefit
Third-party administrator offering ketamine therapy as an add-on employer benefit. First insurer explicitly covering psychedelic therapy.
ℹ
Off-label IV ketamine is a different story. While Spravato is broadly covered, off-label IV ketamine infusions are almost never reimbursed by insurance — because they're not FDA-approved for mental health indications. The drug is the same molecule; the approval status creates the coverage difference. This is why Spravato may actually be the smarter financial choice even if it feels less "clinical" than an IV.
Growing legal access
Psilocybin — retreats vs. licensed US sessions
Psilocybin access falls into two main buckets: licensed, regulated sessions in Oregon and Colorado, and retreat-based experiences internationally. The cost difference is substantial; so is the experience.
🏛
Oregon & Colorado licensed psilocybin
Legal in-state · Regulated facilitator · No prescription needed
✗ Not covered
| Component | Typical cost | Notes |
|---|
| Preparation session(s) | $150–$400 | 1–3 sessions; some included in package |
| Psilocybin product | $100–$500 | Billed separately from facilitation |
| Facilitation (session day) | $800–$2,000 | 4–8 hours of facilitator time |
| Integration session(s) | $150–$400 | 1–3 sessions recommended |
| All-in package | $1,500–$3,500 | Most centers offer bundled pricing |
💡 Several Oregon service centers offer sliding scale fees and income-based scholarships — this is more common than in the retreat market. Ask directly about financial assistance during intake. The Oregon Psilocybin Services website lists licensed service centers with contact info.
🌿
International psilocybin retreats
Jamaica · Netherlands · Mexico · Costa Rica · Peru · Portugal and more
✗ Not covered
| Location / tier | Typical range | What's usually included |
|---|
| Budget retreats (Mexico, Jamaica) | $1,600–$3,500 | 2–4 nights, 1–2 ceremonies, basic accommodation |
| Mid-tier (Netherlands, Jamaica) | $3,500–$6,500 | 3–7 nights, 2–3 ceremonies, prep/integration, meals |
| Premium (Jamaica, Costa Rica, Peru) | $6,500–$14,000 | Week+, multiple ceremonies, full integrative programming, private rooms |
| Plus: flights | $300–$1,500 | Varies significantly by origin and destination |
💡 The retreat price varies enormously based on accommodation quality and staff ratios, not just substance or ceremony count. A $3,000 Jamaica retreat and a $3,000 Netherlands retreat are very different experiences. Read the
retreat vetting guide before booking on price alone.
Not FDA approved — limited access
MDMA therapy — costs in a pre-approval landscape
MDMA-assisted therapy is not FDA approved as of 2024, which means there is no legal commercial pathway in the US. Access currently comes through clinical trials (free), licensed therapy in Australia, or underground practitioners.
🔬
MDMA-assisted therapy — current pathways
Not FDA approved · Clinical trial is primary US access
✗ Not covered (not approved)
| Pathway | Cost | Notes |
|---|
| US clinical trial | Free | Must meet eligibility criteria; primarily PTSD focus. See ClinicalTrials.gov. |
| Australia (licensed, post-2023) | ~AUD $10,000–$25,000 | Authorized prescriber pathway; insurance not yet covered. Significant out-of-pocket. |
| Underground (US) | $3,000–$8,000 | No regulatory oversight; legal risk; quality and safety vary widely. Not recommended. |
💡 The most responsible path to MDMA therapy in the US right now is a clinical trial. The MAPS therapist integration list connects people with integration-trained therapists while trials are ongoing. Watch for ongoing Lykos Phase 3 recruitment.
Search MDMA trials →
Highest cost, highest risk, highest barrier
Ibogaine — the most expensive pathway
Ibogaine has the most substantial medical requirements of any substance on this site — which drives cost significantly. The medical supervision required isn't bureaucratic overhead; it's the mechanism by which a dangerous drug becomes safer.
🌱
Ibogaine treatment
Mexico · Portugal · Not legal in US · 24–36 hour experience · Medical supervision required
✗ Not covered
| Tier | Cost range | What's included |
|---|
| Basic medical clinic (Mexico) | $5,000–$8,000 | Medical screening, ibogaine treatment, 3–5 day stay |
| Full-service clinic (Mexico/Portugal) | $8,000–$14,000 | Cardiac monitoring, prep/integration, 7–10 day program |
| Premium (Baja, Portugal) | $14,000–$18,000 | Full medical team, extended stay, aftercare program |
| Plus: flights + travel | $400–$1,500 | Mexico closest for most US residents |
⚠️ The cost difference between clinics often reflects the quality of medical supervision — specifically cardiac monitoring capability. Given ibogaine's QTc risk, paying for a clinic with on-site cardiac care is not a luxury. A cheaper clinic that lacks this infrastructure is not a bargain.
See ibogaine safety profile →
⚠️
Veteran-specific programs: Several organizations offer subsidized or grant-funded ibogaine and 5-MeO-DMT treatment specifically for veterans with PTSD and TBI. Heroic Hearts Project, Vets Solutions, and Mission Within all provide financial assistance and vetted clinical referrals for veterans who qualify. The Stanford 2024 ibogaine-for-veterans study has increased both research funding and attention to this population.
The free pathway
Clinical trials — free access with real therapeutic intent
Clinical trials are underutilized. Many people assume they're for researchers, not patients — but trials for treatment-resistant conditions are explicitly designed to help people who haven't responded to conventional treatment. The medicine, sessions, preparation, and integration are all provided at no cost. Some pay stipends.
🔬
278 psychedelic clinical trials were registered on ClinicalTrials.gov as of mid-2024 — up from a handful a decade ago. Hopkins, NYU, UCSF, Imperial College London, and dozens of other institutions are actively recruiting. Phase 2 and Phase 3 trials specifically need participants who meet clinical criteria, not healthy volunteers.
✓ Free — treatment sponsored
Psilocybin for treatment-resistant depression
Multiple Phase 2 and Phase 3 trials actively recruiting. Hopkins, NYU, and Compass Pathways are the major sponsors. Eligibility typically requires two or more failed antidepressant trials. Sessions, preparation, and integration are all provided at no cost. Some trials pay $50–$200 per visit in travel stipends.
Search open psilocybin trials →
✓ Free — treatment sponsored
MDMA for PTSD
Lykos (formerly MAPS PBC) is actively conducting a new Phase 3 trial following the FDA's 2024 request for additional data. Other independent PTSD trials are ongoing at multiple institutions. PTSD diagnosis with symptom severity criteria is typically required.
Search open MDMA trials →
✓ Free — treatment sponsored
Psilocybin for addiction (alcohol, tobacco)
Hopkins and NYU are leaders here. Tobacco cessation trials have shown remarkable results (67% abstinence at 12 months) and have continued to recruit. Alcohol use disorder trials are Phase 2 with multiple institutions. These are some of the most accessible trials for motivated participants.
Search addiction trials →
✓ Free — treatment sponsored
Ketamine for depression and PTSD
Hundreds of ketamine trials are ongoing — making this the most accessible clinical trial pathway by volume. Some focus on IV infusions, others on esketamine, others on ketamine combined with psychotherapy. Academic medical centers often have easier enrollment than pharmaceutical-sponsored trials.
Search ketamine trials →
$ Stipend — healthy volunteers
Healthy volunteer studies
Phase 1 and basic research studies recruit healthy volunteers — people without clinical diagnoses — to study pharmacology, dosing, and brain imaging effects. These typically pay $200–$1,500 in total compensation. You receive the substance but are participating for research, not therapeutic purposes.
Search healthy volunteer studies →
◑ Partial — expanded access
Expanded access (compassionate use)
The FDA's expanded access pathway theoretically allows access to investigational drugs outside trials. In practice it's rarely used for psychedelics — the regulatory burden on providers is high. Canada's Special Access Program and Australia's authorized prescriber pathway are more functional equivalents internationally.
FDA expanded access info →
ClinicalTrials.gov is the authoritative database of all registered US trials. Psychedelic.support also maintains a curated trial finder. When evaluating a trial, check: Phase (2 or 3 are most therapeutic in intent), eligibility criteria, compensation, location, and expected time commitment. Some trials require 6–12 months of follow-up visits after the main sessions.
If you can't afford full cost
Financial assistance programs
Several organizations explicitly fund access for people who can't afford out-of-pocket costs. These are real programs with real funding — not a vague suggestion to "ask about scholarships."
💊
Janssen SpravatoWithMe (for Spravato)
Caps your copay at $10/session with up to $8,150 annual benefit for commercially insured patients. Administered through your treatment center. If you have insurance that covers Spravato, this program nearly eliminates out-of-pocket cost. Apply through your Spravato provider. spravato.com →
🏛
Janssen Patient Assistance Foundation (JJPAF)
For uninsured or underinsured patients who qualify, JJPAF can provide Spravato at no cost. Income-based eligibility. Note: anti-kickback rules prevent J&J from directly subsidizing Medicare patients' copays, but JJPAF operates as an independent nonprofit. jjpaf.org →
🎖
Heroic Hearts Project (Veterans)
Provides grants and subsidized access to psychedelic therapy for veterans with PTSD, specifically for retreats and clinical programs. Partners with vetted international facilities. Application-based; focuses on veterans who have not responded to conventional VA treatment. heroichearts.org →
🎖
Mission Within (Veterans)
Funds ibogaine and 5-MeO-DMT treatment for veterans, particularly those with TBI and PTSD. Referrals to vetted medical clinics in Mexico. Grant funding covers most or all treatment costs for qualifying veterans. Rigorous clinical screening included. missionwithin.org →
🌿
Retreat scholarships and sliding scale
A growing number of retreat centers — particularly in Oregon and Jamaica — offer income-based sliding scale pricing or scholarship spots. This is more common than widely known and rarely advertised prominently. Contact centers directly and ask explicitly: "Do you offer scholarship or sliding scale pricing?" Budget 20–30% of centers in the higher-end market have some form of this.
🏥
HSA / FSA accounts
Health Savings Accounts and Flexible Spending Accounts can generally be used for off-label IV ketamine infusions as they are medical procedures. Spravato qualifies. Therapy sessions (preparation and integration) typically qualify. Retreat costs are generally not eligible. Check with your plan administrator — rules vary by employer. Using pre-tax dollars effectively discounts the cost by your marginal tax rate (typically 22–32%).
📋
Out-of-network insurance reimbursement
If your insurance plan includes out-of-network benefits (typically PPO plans, not HMO), you may be able to submit claims for ketamine infusions and receive 50–70% reimbursement. This requires a superbill from the clinic with appropriate billing codes. CPT codes for psychedelic medication therapy monitoring were created by the AMA in 2023, which has improved reimbursement infrastructure. Ask your clinic if they provide superbills.
Practical strategies
Eight ways to reduce what you pay
01
Start with Spravato if it fits
If ketamine is appropriate for your condition and you're on antidepressants, Spravato is the only insurance-covered option. Even if IV ketamine "feels" more clinical, the financial difference with good insurance is enormous — $10–50/session vs. $400–800.
02
Apply for a clinical trial first
Before spending anything out-of-pocket on psilocybin or MDMA therapy, check whether you're eligible for a trial. If you have treatment-resistant depression or PTSD, you likely meet criteria for at least some open trials. The care quality at top research institutions is excellent.
03
Bill therapy separately
For KAP and retreat prep/integration, the psychotherapy component is often separately billable to insurance. Ask your therapist or clinic to provide a superbill coded for psychotherapy. Even when the drug itself isn't covered, several hundred dollars of therapy per course often is.
04
Use HSA/FSA strategically
Max your HSA/FSA before paying for ketamine infusions or therapy sessions. The tax savings are significant — pre-tax dollars effectively discount your costs by 22–32% depending on your bracket. Plan ahead; HSA contributions require enrollment in a qualifying high-deductible health plan.
05
Ask about group formats
Some psilocybin service centers and ketamine clinics offer group sessions that significantly reduce per-person costs. Group psilocybin sessions in Oregon can run 30–50% less than private sessions. The therapeutic model is different — both approaches have merit, and the cost difference can be significant.
06
Oregon over international
For US residents, Oregon's licensed psilocybin sessions at $1,500–$3,500 all-in are often comparable to or cheaper than international retreats once flights are included. And you don't have to travel internationally. The experience differs (more clinical, less ceremonial) but the cost math often favors Oregon.
07
Appeal insurance denials
30% of Spravato prior authorization denials are reversed on appeal. If you're denied, request a peer-to-peer review immediately — this puts your psychiatrist in direct contact with the insurance medical director. Have your psychiatrist document specifically why alternatives were inadequate.
08
Ask every center about assistance
Sliding scale and scholarship programs at retreat centers and Oregon service centers are real but rarely advertised prominently. The question to ask: "Do you have any scholarship, sliding scale, or financial assistance for people who can't afford full cost?" Budget a meaningful minority of centers to say yes.
Continue
Ready to take next steps?